Edgewise Therapeutics Inc at JPMorgan Healthcare Conference Transcript
Welcome, everyone, to the 40th annual JPMorgan healthcare conference. My name is Tess Romero; I am one of the senior biotech analysts here at JPMorgan. I am joined by Taylor Hanley from the team.
Our next presenting company is Edgewise Therapeutics and presenting on behalf of the Company, we have CEO Kevin Koch. Kevin, thanks so much for joining us. Before I hand it over to you, I would just like to remind all our listeners to use the ask a question feature in the portal in order to ask your question and I can ask it on your behalf.
With that, over to you, Kevin.
Thank you very much, Tessa. Before I get started, like to thank you all for joining the call today. And like to begin, I would like to remind you that we are making forward-looking statements during the presentation today. Please refer to our public filings for discussions of the risks associated with making predictions about the future of our programs.
As an introduction to
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
